Ozden Demır

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyObstetrics and gynaecologyPredictive and prognostic markersEnvironmental rehabilitation and restoration
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 13, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).

Ozden Demir, Bulent Cetin, Ali Alkan

|Nov 12, 2025
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy.

Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel

|May 10, 2023
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac

|Dec 10, 2022
Prospective evaluation of hematological parameters in preoperative renal cell cancer patients.

Ozden Demir, Guzin Demirag, Gokhan Aslan

|Jul 14, 2022
A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure.

Ozden Demir, Guzin Demirag

Pageof 1